NHF 2023 Video: Safety and efficacy of gene therapy for hemophilia in HIV-positive participants
NHF 2023 Video: Safety and efficacy of gene therapy for hemophilia in HIV-positive participants https://sparktherapeuticscongresses.com/uploads/2023/08/NHF-2023-HIV_HCV-poster-video_FINAL.mp4 Download FIle
NHF 2023 Poster: Safety and efficacy of gene therapy for hemophilia in HIV-positive participants
NHF 2023 Poster: Safety and efficacy of gene therapy for hemophilia in HIV-positive participants Download FIle
NHF 2023 Video: Improved quality of life in people with hemophilia A following gene therapy with dirloctocogene samoparvovec (SPK-8011)
NHF 2023 Video: Improved quality of life in people with hemophilia A following gene therapy with dirloctocogene samoparvovec (SPK-8011) https://sparktherapeuticscongresses.com/uploads/2023/08/NHF-QoL-poster-video_FINAL.mp4 Download FIle
NHF 2023 Poster: Improved quality of life in people with hemophilia A following gene therapy with dirloctocogene samoparvovec (SPK-8011)
NHF 2023 Poster: Improved quality of life in people with hemophilia A following gene therapy with dirloctocogene samoparvovec (SPK-8011) Download FIle
NHF 2023 Video: Long-term factor VIII expression with reduced bleeding following gene transfer for hemophilia A: follow-up on the dirloctocogene samoparvovec (SPK-8011) phase I/II trial
NHF 2023 Video: Long-term factor VIII expression with reduced bleeding following gene transfer for hemophilia A: follow-up on the dirloctocogene samoparvovec (SPK-8011) phase I/II trial https://sparktherapeuticscongresses.com/uploads/2023/08/NHF-2023-SPK-8011-poster-video_FINAL.mp4 Download FIle
NHF 2023 Poster: Long-term factor VIII expression with reduced bleeding following gene transfer for hemophilia A: follow-up on the dirloctocogene samoparvovec (SPK-8011) phase I/II trial
NHF 2023 Poster: Long-term factor VIII expression with reduced bleeding following gene transfer for hemophilia A: follow-up on the dirloctocogene samoparvovec (SPK-8011) phase I/II trial Download FIle